NEW MJ NEWS

TerrAscend to Participate in the ATB Capital Markets 11th Annual Institutional Investor Conference

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that its executive management team will participate in the ATB Capital Markets 11th Annual Institutional Investor Conference being held January 10-12, 2023.

Ziad Ghanem, President and Chief Operating Officer, will participate on the virtual panel, “Managing New Jersey’s Crazy Traffic”, at 11:10 AM ET on Thursday, January 12, 2023. Mr. Ghanem and other members of management, including Jason Wild, Executive Chairman and Keith Stauffer, Chief Financial Officer, will also be available for one-on-one meetings throughout the day. Please contact your ATB representative if you have interest in scheduling a meeting.

About TerrAscend

TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania, New Jersey, Michigan and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit www.terrascend.com.

SOURCE TerrAscend

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2023/11/c9565.html


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CBIS Follows Through With a Full Clinical Drug Development Agreement

After Successful Formulation Work, Cannabis Science Follows Through With a Full Clinical…

AbbVie Inc. (ABBV) Highlights Innovative Research From Its Rheumatology Portfolio

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021…

$MDBX to Purchase 320-Acres of Agricultural Land in Colorado

Medbox to Purchase 320-Acres of Agricultural Land in Colorado  Medbox, Inc. (OTCQB:…

ICC International Cannabis Corp. (KNHBF) Increases European Distribution Footprint by Over 1,300 Pharmacies

International Cannabis Increases European Distribution Footprint by Over 1,300 Pharmacies ICC International…